Go backIncome
Assets
Liabilities
Other
UAB "Novo Nordisk Pharma"
Novo Nordisk Pharma
is not in process of liquidation on May 1, 2024
To view all financial indicators, unlock this company.
Income
Financial indicator20192018
Net sales
11.3M EUR
3%
10.9M EUR
-6%
Net profit
251K EUR
-24%
328K EUR
-7%
Profit before tax
░░░░░░░░
0%
░░░░░░░░
0%
Assets
Financial indicator20192018
Fixed assets
18.6K EUR
-5%
19.5K EUR
-52%
Current assets
░░░░░░░░
0%
░░░░░░░░
0%
Equity
░░░░░░░░
0%
░░░░░░░░
0%
Liabilities
Financial indicator20192018
Payables and liabilities
░░░░░░░░
0%
░░░░░░░░
0%
Your trusted source for business data
Socials
English, USA
English, USA